47 completed, 9 unknown, 6 recruiting, 6 terminated. 22 Phase 2, 17 Phase 4, 14 Phase 1, 14 Phase 3, 12 Not applicable.
Follow Clobetasol: new trials by email Literature Review of Clobetasol trials Research Report on Clobetasol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Clobetasol Vs Intralesional Triamcinolone in Lichen Planus Treatment Clobetasol propionate 0.05% cream, Triamcinolone acetonide 10 mg/mL injection - Hypertrophic Lichen Planus | Phase 4 | Not yet recruiting | Noor Aziz | 50 | 2026-10-01 | 2026-06-24 |
| The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) Triamcinolone (Optional), control group - Post Cataract Surgery | Phase 4 | Not yet recruiting | Research Insight LLC | 40 | 2026-04-01 | 2026-03-31 |
| Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy. Platelet-Rich Plasma (PRP) Treatment, Clobetasol Propionate 0.05% Cream (Dermovate), Pimecrolimus Cream (Elidel) - Vulvar Lichen Sclerosus | Not applicable | Not yet recruiting | Milosz Pietrus | 45 | 2025-12-01 | 2025-11-20 |
| Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris. Clobetasol propionate 0.05% Mouthwash, diode laser for photobiomodulation, clobetasol propionate 0.05% mouthwash + photobiomodulation - Oral Lesions in Patients With Pemphigus Vulgaris | Not applicable | Recruiting | Damascus University | 30 | 2025-11-01 | 2026-06-11 |
| Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo Microneedling with 5-fluorouracil, Topical application of 0.05% Clobetasol propionate - Vitiligo | Early Phase 1 | Recruiting | Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan | 40 | 2025-08-08 | 2026-02-17 |
| Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? Bimekizumab, Clobetasol - Psoriasis | Phase 2 | Recruiting | Centre Hospitalier Universitaire de Nice | 40 | 2025-07-22 | 2026-10-01 |
| ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction Zinc Supplementation, Clobetasol Propionate 0.05% Cream - Hand-Foot Skin Reaction (HFSR) | Not applicable | Completed | Gazi University | 150 | 2025-02-20 | 2025-09-15 |
| Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus Clobetasol Patch, Clobetasol + Resveratrol Patch, Clobetasol in Orabase - Oral Lichen Planus, Oral Lichen Planus Related Stress | Phase 2 | Recruiting | University of Palermo | 45 | 2024-09-04 | 2025-08-03 |
| Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib Amivantamab IV, Amivantamab SC, Lazertinib - Carcinoma, Non-Small-Cell Lung | Phase 2 | Active not recruiting | Janssen Research & Development, LLC | 305 | 2024-02-16 | 2026-09-25 |
| Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus Treatment with Monalisa Glide Laser, Treatment with Clobetasol - Lichen Sclerosus | Not applicable | Recruiting | Kantonsspital Winterthur KSW | 120 | 2023-11-10 | 2025-09-23 |
| Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis 0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate - Psoriasis Vulgaris | Phase 4 | Completed | Dermatology Consulting Services, PLLC | 10 | 2023-07-13 | 2023-11-18 |
| A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study Photodynamic Therapy, Clobetasol - Oral Lichen Planus | Phase 2 | Completed | Wroclaw Medical University | 29 | 2023-06-01 | 2024-12-30 |
| Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population Clobetasol Propionate, Prednisolone acetate ophthalmic suspension, 1% - Cataracts Infantile | Phase 3 | Unknown | Salvat | 60 | 2022-12-12 | 2024-09-27 |
| Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis GN-037, Clobetasol 17-propionate, Placebo - Psoriasis | Phase 2 | Completed | GEN İlaç ve Sağlık Ürünleri A.Ş. | 190 | 2022-12-07 | 2025-07-16 |
| Silver Nitrate Versus Topical Steroid For Umbilical Granuloma Clobetasol Propionate .05 Mg in 100 mL TOPICAL LOTION, Silver Nitrate - Umbilical Granuloma | Phase 2 | Completed | Children Hospital and Institute of Child Health, Lahore | 354 | 2022-09-20 | 2024-04-12 |
| Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? MonaLisa Touch, Topical steroid - Vulvar Lichen Sclerosus | Phase 2 / Phase 3 | Terminated | University of South Alabama | 11 | 2022-04-13 | 2025-06-18 |
| Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus Fractionated CO2-laser, Clobetasol Propionate 0.05% Ointment - Vulvar Lichen Sclerosus | Phase 4 | Completed | Medstar Health Research Institute | 212 | 2022-03-01 | 2025-06-05 |
| Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis topical 1% methotrexate gel, clobetasol propionate 0.05% ointment - Pilot Study, Psoriasis | Early Phase 1 | Completed | Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium | 2 | 2022-01-01 | 2024-08-16 |
| Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva PRGF, Clobetasol Propionate - Lichen Sclerosus of Vulva | Phase 3 | Withdrawn | Fundación Eduardo Anitua | 2021-12-23 | 2025-02-27 | |
| Laser vs Clobetasol for Lichen Sclerosus Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser - Lichen Sclerosus | Phase 3 | Completed | Ruhr University of Bochum | 246 | 2021-11-02 | 2025-12-04 |
Showing 20 of 76. Sign in to see all of them.
Psoriasis (17) · Vulvar Lichen Sclerosus (8) · Lichen Planus, Oral (7) · Inflammation (4) · Lichen Sclerosus et Atrophicus (4) · Dermatitis, Atopic (3) · Pain (3) · Pemphigoid, Bullous (3) · Alopecia (2) · Cataract (2) · Colorectal Neoplasms (2) · Dermatitis (2) · Skin Diseases (2) · Alopecia Areata (1) · Arthritis, Rheumatoid (1)
Galderma R&D (4) · Bayer (3) · LEO Pharma (3) · Salvat (3) · Stiefel, a GSK Company (3) · Actavis Inc. (2) · Assistance Publique - Hôpitaux de Paris (2) · Cairo University (2) · Medstar Health Research Institute (2) · Academic and Community Cancer Research United (1) · Azidus Brasil (1) · Callender Center for Clinical Research (1) · Center for Vulvovaginal Disorders (1) · Centre Hospitalier Universitaire de Nice (1) · Centre Hospitalier Universitaire, Amiens (1)
United States (29) · Germany (9) · France (7) · Brazil (5) · Canada (4) · Pakistan (3) · Poland (3) · Turkey (Türkiye) (3) · Denmark (2) · Spain (2) · Switzerland (2) · Taiwan (2) · Argentina (1) · China (1) · Egypt (1)
Andrew Schwartz, MD (2) · Ronald W Gottschalk, MD (2) · Soran Hong,, M.D. (2) · Abeer Aljoujou, PhD In Oral medicine (1) · Adeel A Gujjar, M.S (1) · Amy J McMichael, MD (1) · Anders Clemmensen, MD (1) · Andrew T Goldstein, MD (1) · Benjamin Batteux, MD (1) · Catherine Lok, Pr (1) · Cesar W. Noce, DDS, MSD (1)
PMID 12424394, PMID 14977340, PMID 24935281, PMID 27810317, PMID 28670710, PMID 42192627, PMID 15568399, PMID 21353334, PMID 22134563, PMID 25592341, PMID 26297574, PMID 28712102, PMID 28793884, PMID 30297352, PMID 31262657, PMID 32726554, PMID 33957642, PMID 34251533, PMID 37145134, PMID 37300792, PMID 38508975, PMID 38754628, PMID 39578347, PMID 39998969, PMID 40923969, PMID 41807108, PMID 42163196, PMID 42208069, PMID 42384057
2008 (1), 2016 (1), 2023 (1), P30CA015083 (1)